Umeclidinium bromide
id:
umeclidinium-bromide-279-11614225
title:
Umeclidinium bromide
text:
Umeclidinium bromide, sold under the brand name Incruse Ellipta, is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is also approved for this indication in combination with vilanterol and also as a triple-therapy combination as fluticasone furoate/umeclidinium bromide/vilanterol. It is on the World Health Organization's List of Essential Medicines. In 2020, it was the 245th most commonly prescribed medication in the U
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Umeclidinium_bromide
date created:
date modified:
2024-04-03T04:08:45Z
main entity:
{"identifier":"Q15624035","url":"https://www.wikidata.org/entity/Q15624035"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b9/Umeclidinium_bromide.svg","width":1265,"height":1140}
fields total:
13
integrity:
15